In a hospital in northern Norway, just south of the Arctic Circle, a landmark experiment is taking place that could transform the way we treat ageing in the years to come. Called ExPlas – exercised plasma – the clinical trial involves taking blood plasma from young and healthy adults who exercise on a regular basis and injecting it into people aged between 50 and 75 in the early stages of Alzheimer’s disease. It’s the first time this has been tested in humans.
The full results will be available in 2025, and the hope is that it will represent a new way of rejuvenating the minds and bodies of older people, and perhaps one day even all of us who lead largely sedentary lives.
Scientists have long known that exercise is arguably the best medicine of all. Studies have found that exercising can slash the risk of dementia by up to 45%, along with maintaining strong bones, supple blood vessels and muscle fibres that replenish themselves rather than fading away.
8 Likes